Suvretta Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38M | Buy |
353,561
+91,462
| +35% | +$9.82M | 1.14% | 29 |
|
|
2025
Q1 | $26.4M | Sell |
262,099
-135,580
| -34% | -$13.7M | 0.98% | 31 |
|
|
2024
Q4 | $35.5M | Buy |
397,679
+145,990
| +58% | +$13M | 1.21% | 29 |
|
|
2024
Q3 | $21.1M | Hold |
251,689
| – | – | 0.67% | 44 |
|
|
2024
Q2 | $19.4M | Sell |
251,689
-51,346
| -17% | -$3.95M | 0.71% | 39 |
|
|
2024
Q1 | $20.8M | Sell |
303,035
-391,066
| -56% | -$26.8M | 0.77% | 38 |
|
|
2023
Q4 | $40.1M | Buy |
694,101
+340,360
| +96% | +$19.7M | 1.81% | 19 |
|
|
2023
Q3 | $18.7M | Buy |
353,741
+335,500
| +1,839% | +$17.7M | 1.01% | 32 |
|
|
2023
Q2 | $987K | Hold |
18,241
| – | – | 0.05% | 87 |
|
|
2023
Q1 | $913K | Buy |
18,241
+4,100
| +29% | +$205K | 0.04% | 79 |
|
|
2022
Q4 | $654K | Buy |
+14,141
| New | +$654K | 0.03% | 72 |
|
|
2020
Q3 | – | Sell |
-455,000
| Closed | -$16M | – | 96 |
|
|
2020
Q2 | $16M | Sell |
455,000
-4,089,220
| -90% | -$144M | 0.34% | 48 |
|
|
2020
Q1 | $148M | Buy |
4,544,220
+2,868,710
| +171% | +$93.6M | 4% | 8 |
|
|
2019
Q4 | $75.8M | Sell |
1,675,510
-43,889
| -3% | -$1.98M | 1.72% | 27 |
|
|
2019
Q3 | $70M | Sell |
1,719,399
-949,001
| -36% | -$38.6M | 1.81% | 22 |
|
|
2019
Q2 | $115M | Sell |
2,668,400
-409,000
| -13% | -$17.6M | 2.43% | 14 |
|
|
2019
Q1 | $118M | Buy |
3,077,400
+778,946
| +34% | +$29.9M | 3.42% | 7 |
|
|
2018
Q4 | $81.2M | Sell |
2,298,454
-79,016
| -3% | -$2.79M | 4.84% | 6 |
|
|
2018
Q3 | $91.5M | Buy |
+2,377,470
| New | +$91.5M | 2.11% | 16 |
|